Last reviewed · How we verify
CVN424 High Dose
At a glance
| Generic name | CVN424 High Dose |
|---|---|
| Also known as | CVN424 |
| Sponsor | Cerevance Beta, Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Relative Bioavailability and Food Effect Study of CVN424 (PHASE1)
- Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |